Coffin to Lead New Illuminas Healthcare Practice

UK-based Illuminas has appointed former Holden Pearmain Healthcare Director Dan Coffin to lead its new global Healthcare practice.

With offices in London, New York and Austin, TX, Illuminas works in a range of sectors from tech and financial markets to retail and kids.

Coffin (pictured) joins with a fourteen-year background in global market research. Most recently, at Holden Pearmain he was responsible for the overall healthcare business, and prior to this he served as Healthcare Director at Hall & Partners after spells at Isis Research, LifeScan and Roche Pharmaceuticals.

In his new role, Coffin will work with pharma clients in areas such as clinical and commercial development, opportunity analysis, marketing strategy and product launch, using segmentation, pricing and conjoint-based approaches.

John Connaughton, Illuminas CEO, comments: 'Dan fits perfectly with the Illuminas philosophy of offering bespoke, method-neutral solutions to solve complex business problems. It's great to welcome someone with Dan's sector experience to be able to apply our capabilities in high-end qual, quant and marketing sciences to the healthcare sector.'

Web site: www.illuminas-global.com .